Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-19T15:02:13.865Z Has data issue: false hasContentIssue false
  • English
  • Français

Clopenthixol Decanoate in the Management of Aggressive Mentally Handicapped Patients

Published online by Cambridge University Press:  29 January 2018

T. J. J. Mlele  and
Yvonne V. Wiley
T. J. J. Mlele
Affiliation:
Stoke Park Hospital and University of Bristol
Yvonne V. Wiley*
Affiliation:
Stoke Park Hospital and University of Bristol
*
Correspondence
Get access Rights & Permissions [Opens in a new window]

Extract

The management of aggressive and disruptive behaviour in mentally handicapped patients is a severe problem, and it is widely accepted that drug therapy is only one component in the range of measures required for a comprehensive regime, although the use of depot phenothiazines is widespread (Craft & Schiff, 1980). The evidence for their therapeutic effectiveness in the mentally handicapped is usually empirical, and sometimes based on anecdotal evidence. Clopenthixol decanoate is widely used in the management of aggressive and disruptive behaviour in such patients, probably as a result of experience of the use of this drug in schizophrenic patients. Carney & Rutherford (1981) reported a marked improvement in both aggressive and non-aggressive behaviour disorders in 20 chronic schizophrenic patients treated for 11 months with clopenthixol decanoate, while Visiwanathan & Rajhkowa (1982) stated that it was of undoubted value in the management of chronic in-patients, especially those with ‘positive affective’ symptoms such as hostility, aggression, suspiciousness, and irritability.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 149 , Issue 3 , September 1986 , pp. 373 - 376
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carney, M W P. & Rutherford, P. (1981) Clopenthixol decanoate in schizophrenia. Current Medical Reserach and Opinion, 7, 205–211.Google Scholar
Craft, M. J. & Schiff, A. A. (1980) Psychiatric disturbance in mentally handicapped patients. British Journal of Psychiatry, 137, 250–255.CrossRefGoogle ScholarPubMed
Shepherd, M. (1975) The evaluation of treatments in psychiatry. In Methods of Psychiatric Research (eds Sainsbury, P. & Kreitman, N.). London: Oxford University Press.Google Scholar
Viswanaihan, R. & Rajhkowa, S. (1982). Clopenthixol in the treatment of chronic schizophrenic in-patients. Pharmatherapeutica, 3, 93–99.Google Scholar
Yar-Khan, (1981) The psychiatrically violent patient. British Medical Journal, 282, 1400–1401.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.